MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.rpor.2020.04.001

Медицинская библиотека · Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology · 2020

Should high-dose-rate brachytherapy boost be used in early nasopharyngeal carcinomas?

Guinot Jose Luis, Moya Andrea, Santos Miguel Angel, Peña Marina, Quiles Beatriz, Sanchez-Relucio Juan Carlos, La Rosa Alonso, Tortajada Maria Isabel, Arribas Leoncio

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Radiation with or without chemotherapy is the main treatment of nasopharyngeal carcinomas (NPC). Local recurrence is difficult to manage. Local control is dose-dependent.

AIM: To analyze the effect of an endocavitary brachytherapy boost after external beam radiation (EBRT) to decrease local recurrence.

MATERIAL AND

METHODS

Thirty patients with T0-T2 NPC were treated: 70% T1, 20% T2 and 10% T0; 33.3% N0, 20% N1, 43.3% N2 and 3.3% N3; 90% were undifferentiated carcinoma. All they received a 192-Ir high dose rate brachytherapy (HDR-BT) boost after 60 Gy of EBRT. The Rotterdam applicator was used in most cases, 3-4 fractions of 3.75-3 Gy in two days.

RESULTS

With median follow-up (FU) of 63 months, a single parapharyngeal failure resulted in local control of 100% at 3 years and 95% at 5 years. Local control for T0-1 was 100% and for T2 67% at five years (p = 0.02). Regional-free recurrence survival was 92% at 5 years. Metastasis-free survival was 84% at 5 years. All cases of metastasis had histopathology of undifferentiated. The overall and cause-specific survival was 96% and 86% at 3 and 5 years. No late complications related to brachytherapy were described.

CONCLUSION

A HDR-BT boost is useful to decrease the incidence of local recurrence of NPC to 5%. With a fractionated schedule of 3-4 fractions in two days, Rotterdam applicator and 3-D planning, no late complications are described. Therefore we recommend to use brachytherapy boost in all early NPC.

Для цитирования: Guinot Jose Luis, Moya Andrea, Santos Miguel Angel, Peña Marina, Quiles Beatriz, Sanchez-Relucio Juan Carlos, La Rosa Alonso, Tortajada Maria Isabel, Arribas Leoncio. Should high-dose-rate brachytherapy boost be used in early nasopharyngeal carcinomas?. Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology. 2020. DOI: 10.1016/j.rpor.2020.04.001.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.